Estia Health downgrades guidance

Company News

by Rachael Jones

Aged care provider Estia Health (ASX:EHE) saw their NPAT for the half year to December 31 2018 up 4.1 per cent to $21.1 million.

Revenue is up 6.6 per cent to $289.7 million on the prior corresponding period.

EBITDA is also up 3.1 per cent to $46.9 million.

Despite these results Estia Health says it has revised its financial year 2019 guidance to a low to mid single digit percentage increase taking into account that costs arising from the royal commission are not reflected in the guidance.

A fully franked interim dividend of 8.0 cents per share has been declared.

Shares in Estia Health (ASX:EHE) are trading 1.87 per cent lower to $2.37.